Open Government: Use of Genetic Information in Documenting and Evaluating Disability; Extension of Comment Period, 78462-78463 [2013-30805]

Download as PDF 78462 Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices December and January. The Exchange also believes that its proposal is reasonable because it is not changing the thresholds to become eligible or the dollar value associated with the rebates and, moreover, by continuing to exclude odd lots from the calculation of average daily TCV, Members will be more likely to meet the minimum or higher tier thresholds for December and January, which will provide additional incentive to Members to increase their participation on the Exchange in order to meet the next tier. In addition, the Exchange believes that the proposed changes to fees are equitably allocated among Exchange constituents as the methodology for calculating ADV and TCV will apply equally to all Members. Volume-based tiers such as the liquidity adding tiers maintained by the Exchange have been widely adopted in the equities markets, and are equitable and not unfairly discriminatory because they are open to all members on an equal basis and provide rebates that are reasonably related to the value to an exchange’s market quality associated with higher levels of market activity, such as higher levels of liquidity provision and introduction of higher volumes of orders into the price and volume discovery process. Accordingly, the Exchange believes that the proposal is equitably allocated and not unfairly discriminatory because it is consistent with the overall goals of enhancing market quality. B. Self-Regulatory Organization’s Statement on Burden on Competition emcdonald on DSK67QTVN1PROD with NOTICES The Exchange does not believe that the proposed rule change will impose any burden on competition not necessary or appropriate in furtherance of the purposes of the Act. The proposed changes will help the Exchange to continue to incentivize higher levels of liquidity at a tighter spread while providing more stable and predictable costs to its Members. As stated above, the Exchange notes that it operates in a highly competitive market in which market participants can readily direct order flow to competing venues if they deem fee structures to be unreasonable or excessive. C. Self-Regulatory Organization’s Statement on Comments on the Proposed Rule Change Received From Members, Participants, or Others The Exchange has neither solicited nor received written comments on the proposed rule change. VerDate Mar<15>2010 18:06 Dec 24, 2013 Jkt 232001 III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action The foregoing rule change has become effective pursuant to Section 19(b)(3)(A) of the Act 11 and paragraph (f) of Rule 19b–4 thereunder.12 At any time within 60 days of the filing of the proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. IV. Solicitation of Comments Interested persons are invited to submit written data, views and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Comments may be submitted by any of the following methods: Electronic Comments • Use the Commission’s Internet comment form (http://www.sec.gov/ rules/sro.shtml); or • Send an email to rule-comments@ sec.gov. Please include File Number SR– BATS–2013–063 on the subject line. Paper Comments • Send paper comments in triplicate to Elizabeth M. Murphy, Secretary, Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. All submissions should refer to File Number SR–BATS–2013–063. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s Internet Web site (http://www.sec.gov/ rules/sro.shtml). Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549, on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of such 11 15 12 17 PO 00000 U.S.C. 78s(b)(3)(A). CFR 240.19b–4(f). Frm 00138 Fmt 4703 filing also will be available for inspection and copying at the principal office of the Exchange. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–BATS– 2013–063 and should be submitted on or before January 16, 2014. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.13 Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2013–30761 Filed 12–24–13; 8:45 am] BILLING CODE 8011–01–P SOCIAL SECURITY ADMINISTRATION [Docket No. SSA–2013–0054] Open Government: Use of Genetic Information in Documenting and Evaluating Disability; Extension of Comment Period Social Security Administration. Notice of extension of comment AGENCY: ACTION: period. On November 26, 2013, we announced in the Federal Register that we were soliciting ideas and comments about the use of genetic information in the disability determination process via an online forum. We stated that the forum would be open until December 26, 2013. We are extending that deadline until January 16, 2014. DATES: The forum will be open for your ideas and comments until January 16, 2014. FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Medical Listings Improvement, Social Security Administration, 6401 Security Boulevard, Baltimore, Maryland 21235– 6401, (410) 965–1020. For information on eligibility or filing for benefits, call our national toll-free number, 1–800– 772–1213, or TTY 1–800–325–0778, or visit our Internet site, Social Security Online, at http:// www.socialsecurity.gov. SUPPLEMENTARY INFORMATION: On November 26, 2013, we announced in the Federal Register that we were soliciting ideas and comments about the use of genetic information in the disability determination process via an online forum that would be open until December 26, 2013.1 We have SUMMARY: 13 17 1 78 Sfmt 4703 E:\FR\FM\26DEN1.SGM CFR 200.30–3(a)(12). FR 70617. 26DEN1 Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices decided to extend that deadline until January 16, 2014. We would like the public’s ideas and comments regarding how we should use genetic information within the disability decision process. Under our current, long-standing policy, we do not purchase genetic testing to evaluate disability. However, we do consider all evidence in the record, including genetic testing and other genetic medical evidence, when we make a determination or decision of whether you are disabled.2 We solicited the public’s ideas and comments on the use of genetic information in order to obtain innovative ideas that we could use to improve the disability determination process. Your comments are important to us and we encourage you to share your ideas on any and all related issues. Some of the specific issues we would like information on include: • What role should genetic specialists have in providing medical evidence?; • Should we use direct-to-consumer genetic test results, and if so, how should we use those results?; • How useful is genetic information in determining prognosis and progression of an impairment?; • What role should genetic information have in the continuing disability review process?; CFR 404.1512–404.1513, 404.1520, 416.912– 416.913, and 416.920. emcdonald on DSK67QTVN1PROD with NOTICES 2 20 VerDate Mar<15>2010 18:06 Dec 24, 2013 Jkt 232001 • Can we make determinations regarding known genetic conditions in the absence of genetic test results, and if so, how should we do so?; • What privacy safeguards should we apply when we obtain and use genetic information?; and • Are there any related issues that may inform our future policies? How To Participate The forum is open to all members of the public. To submit your ideas and comments, please go to http://www.ssadisabilityideas.ideascale.com and go to the Campaign entitled ‘‘Genetic Information.’’ You must register at the site before you are able to submit your ideas and comments. Although we will consider all of the ideas and comments we receive, we will not respond to them. Since we will moderate the ideas and comments we receive during regular business hours, your ideas and comments may not be viewable immediately. In most cases, your ideas and comments should be viewable within two business days. Include only information that you wish to make publicly available. Please do not include any personal information, such as Social Security numbers or medical information. Arthur R. Spencer, Associate Commissioner, Office of Disability Programs. [FR Doc. 2013–30805 Filed 12–24–13; 8:45 am] BILLING CODE 4191–02–P PO 00000 Frm 00139 Fmt 4703 Sfmt 4703 78463 DEPARTMENT OF STATE [Public Notice 8574] Summary of the Certification Related to the Khmer Rouge Tribunal On June 26, 2013, Deputy Secretary William Burns signed a required certification for the Khmer Rouge Tribunal, per section 7044(c) of the Department of State, Foreign Operations, and Related Programs Act, 2012 (Division I, Pub. L. 112–74) as carried forward by the Full-Year Continuing Appropriation Act, 2013 (Div. F, Pub. L. 113–6), that the United Nations and the Royal Government of Cambodia are taking credible steps to address allegations of corruption and mismanagement within the Extraordinary Chambers in the Courts of Cambodia (also known as the ‘‘Khmer Rouge Tribunal’’). The Certification and related Memorandum of Justification are to be provided to the appropriate committees of the Congress and published in the Federal Register. I am signing the below to verify and affirm Deputy Secretary Burns signature and meet the requirements for publication of these documents in the Federal Register. Dated: December 10, 2013. Ed Shin, Special Assistant for Deputy Secretary Burns. E:\FR\FM\26DEN1.SGM 26DEN1

Agencies

[Federal Register Volume 78, Number 248 (Thursday, December 26, 2013)]
[Notices]
[Pages 78462-78463]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30805]


=======================================================================
-----------------------------------------------------------------------

SOCIAL SECURITY ADMINISTRATION

[Docket No. SSA-2013-0054]


Open Government: Use of Genetic Information in Documenting and 
Evaluating Disability; Extension of Comment Period

AGENCY: Social Security Administration.

ACTION: Notice of extension of comment period.

-----------------------------------------------------------------------

SUMMARY: On November 26, 2013, we announced in the Federal Register 
that we were soliciting ideas and comments about the use of genetic 
information in the disability determination process via an online 
forum. We stated that the forum would be open until December 26, 2013. 
We are extending that deadline until January 16, 2014.

DATES: The forum will be open for your ideas and comments until January 
16, 2014.

FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Medical 
Listings Improvement, Social Security Administration, 6401 Security 
Boulevard, Baltimore, Maryland 21235-6401, (410) 965-1020. For 
information on eligibility or filing for benefits, call our national 
toll-free number, 1-800-772-1213, or TTY 1-800-325-0778, or visit our 
Internet site, Social Security Online, at http://www.socialsecurity.gov.

SUPPLEMENTARY INFORMATION: 
    On November 26, 2013, we announced in the Federal Register that we 
were soliciting ideas and comments about the use of genetic information 
in the disability determination process via an online forum that would 
be open until December 26, 2013.\1\ We have

[[Page 78463]]

decided to extend that deadline until January 16, 2014.
---------------------------------------------------------------------------

    \1\ 78 FR 70617.
---------------------------------------------------------------------------

    We would like the public's ideas and comments regarding how we 
should use genetic information within the disability decision process. 
Under our current, long-standing policy, we do not purchase genetic 
testing to evaluate disability. However, we do consider all evidence in 
the record, including genetic testing and other genetic medical 
evidence, when we make a determination or decision of whether you are 
disabled.\2\
---------------------------------------------------------------------------

    \2\ 20 CFR 404.1512-404.1513, 404.1520, 416.912-416.913, and 
416.920.
---------------------------------------------------------------------------

    We solicited the public's ideas and comments on the use of genetic 
information in order to obtain innovative ideas that we could use to 
improve the disability determination process. Your comments are 
important to us and we encourage you to share your ideas on any and all 
related issues. Some of the specific issues we would like information 
on include:
     What role should genetic specialists have in providing 
medical evidence?;
     Should we use direct-to-consumer genetic test results, and 
if so, how should we use those results?;
     How useful is genetic information in determining prognosis 
and progression of an impairment?;
     What role should genetic information have in the 
continuing disability review process?;
     Can we make determinations regarding known genetic 
conditions in the absence of genetic test results, and if so, how 
should we do so?;
     What privacy safeguards should we apply when we obtain and 
use genetic information?; and
     Are there any related issues that may inform our future 
policies?

How To Participate

    The forum is open to all members of the public. To submit your 
ideas and comments, please go to http://www.ssa-disabilityideas.ideascale.com and go to the Campaign entitled ``Genetic 
Information.'' You must register at the site before you are able to 
submit your ideas and comments. Although we will consider all of the 
ideas and comments we receive, we will not respond to them. Since we 
will moderate the ideas and comments we receive during regular business 
hours, your ideas and comments may not be viewable immediately. In most 
cases, your ideas and comments should be viewable within two business 
days.
    Include only information that you wish to make publicly available. 
Please do not include any personal information, such as Social Security 
numbers or medical information.

Arthur R. Spencer,
Associate Commissioner, Office of Disability Programs.
[FR Doc. 2013-30805 Filed 12-24-13; 8:45 am]
BILLING CODE 4191-02-P